Development Bank of Japan invests in Towa Pharmaceutical via preferred share private placement

• Development Bank of Japan invested in Towa Pharmaceutical via a preferred share subscription in a private financing round announced July 31, 2026.
• Towa Pharmaceutical is a Japan-based generic drugmaker that also develops health-related businesses focused on extending healthy life expectancy.
• Proceeds are set to fund expansion of in-house manufacturing lines, support partnerships with like-minded companies, strengthen stable supply of off-patent medicines.
• The investment used DBJ’s Supply Chain Resilience and Infrastructure Advancement Fund under its specified investment operations mandate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Development Bank of Japan Inc. published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.